Dietary Vitamin D and its metabolites non-genomically stabilize the endothelium

PLoS ONE

Volumn 10, Issue 10, 2015, Pages

  Gibson, Christopher C ^a,b,c   Davis, Chadwick T ^a,c   Zhu, Weiquan ^a   Bowman Kirigin, Jay A ^a   Walker, Ashley E ^a   Tai, Zhengfu ^d   Thomas, Kirk R ^a,c   Donato, Anthony J ^a   Lesniewski, Lisa A ^a   Li, Dean Y ^a,c,d,e  

^a UNIVERSITY OF UTAH SCHOOL OF MEDICINE   (United States)

^b University of Utah   (United States)

^c Recursion Pharmaceuticals   (United States)

^d SICHUAN PROVINCIAL PEOPLE'S HOSPITAL   (China)

^e VETERANS AFFAIRS MEDICAL CENTER   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CADHERIN; CALCIFEDIOL; COLECALCIFEROL; INTERLEUKIN 1BETA; PROTEIN KINASE C; TUMOR NECROSIS FACTOR ALPHA; VITAMIN D; VITAMIN;

ANIMAL TISSUE; ARTERY PERMEABILITY; ARTICLE; CALCIUM TRANSPORT; CELL JUNCTION; CEREBRAL ARTERY PERMEABILITY; CLINICAL EFFECTIVENESS; CONTROLLED STUDY; ENZYME ACTIVATION; HUMAN; HUMAN CELL; INTERNALIZATION; INTRACELLULAR SIGNALING; MOUSE; NONHUMAN; OUTCOME ASSESSMENT; STRUCTURE ACTIVITY RELATION; VASCULAR DISEASE; VASCULAR ENDOTHELIUM; VASCULAR LEAK; VITAMIN SUPPLEMENTATION; ANALOGS AND DERIVATIVES; ANIMAL; CAPILLARY PERMEABILITY; CELL CULTURE; CYTOLOGY; DRUG EFFECTS; ENDOTHELIUM CELL; METABOLISM;

ANIMALS; CAPILLARY PERMEABILITY; CELLS, CULTURED; CHOLECALCIFEROL; ENDOTHELIAL CELLS; ENDOTHELIUM, VASCULAR; HUMANS; MICE; VITAMINS;

EID: 84948953775     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0140370     Document Type: Article

References (52)

1. de Boer RA. Vitamin D and cardiovascular disease: a jack of all trades? J Renin Angiotensin Aldosterone Syst. 2011; 12(2):123-4. doi: 10.1177/1470320311410923 PMID: 21628360.
2. Wang TJ, Pencina MJ, Booth SL, Jacques PF, Ingelsson E, Lanier K, et al. Vitamin D deficiency and risk of cardiovascular disease. Circulation. 2008; 117(4):503-11. doi: 10.1161/CIRCULATIONAHA. 107.706127 PMID: 18180395.
3. Poole KE, Loveridge N, Barker PJ, Halsall DJ, Rose C, Reeve J, et al. Reduced vitamin D in acute stroke. Stroke. 2006; 37(1):243-5. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4046. PMID: 16322500
4. Anderson JL, May HT, Horne BD, Bair TL, Hall NL, Carlquist JF, et al. Relation of Vitamin D Deficiency to Cardiovascular Risk Factors, Disease Status, and Incident Events in a General Healthcare Population. The American journal of cardiology. 2010; 106(7):963-8. doi: 10.1016/j.amjcard.2010.05.027 PMID: 20854958
5. Janssens W, Bouillon R, Claes B, Carremans C, Lehouck A, Buysschaert I, et al. Vitamin D deficiency is highly prevalent in COPD and correlates with variants in the vitamin D-binding gene. Thorax. 2010; 65(3):215-20. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4047. doi: 10.1136/thx. 2009.120659 PMID: 19996341
6. Dubnov-Raz G, Rinat B, Hemilae H, Choleva L, Cohen A, Constantini N. Vitamin D Supplementation and Upper Respiratory Tract Infections in Adolescent Swimmers: A Randomized Controlled Trial. Pediatric exercise science. 2014. Epub 2014/07/23. doi: 10.1123/pes.2014-0030 PMID: 25050610.
7. Moromizato T, Litonjua AA, Braun AB, Gibbons FK, Giovannucci E, Christopher KB. Association of Low Serum 25-Hydroxyvitamin D Levels and Sepsis in the Critically Ill. Critical Care Medicine. 2014; 42 (1):97-107. doi: 10.1097/CCM.0b013e31829eb7af PMID: 23982028
8. Ng K. Vitamin D for Prevention and Treatment of Colorectal Cancer: What is the Evidence? Current colorectal cancer reports. 2014; 10(3):339-45. doi: 10.1007/s11888-014-0238-1 PMID: 25221464.
9. Shui I, Giovannucci E. Vitamin D status and cancer incidence and mortality. Advances in experimental medicine and biology. 2014; 810:33-51. Epub 2014/09/11. PMID: 25207359.
10. Holick MF. Vitamin D deficiency. N Engl J Med. 2007; 357(3):266-81. doi: 10.1056/NEJMra070553 PMID: 17634462.
11. Ascherio A, Munger KL, Simon KC. Vitamin D and multiple sclerosis. The Lancet Neurology. 2010; 9 (6):599-612. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4051. doi: 10.1016/S1474-4422(10)70086-7 PMID: 20494325
12. Kerr GS, Sabahi I, Richards JS, Caplan L, Cannon GW, Reimold A, et al. Prevalence of vitamin D insufficiency/deficiency in rheumatoid arthritis and associations with disease severity and activity. The Journal of Rheumatology. 2011; 38(1):53-9. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4052. doi: 10.3899/jrheum.100516 PMID: 20952475
13. Amital H, Szekanecz Z, Szücs G, Dankó K, Nagy E, Csépány T, et al. Serum concentrations of 25-OH vitamin D in patients with systemic lupus erythematosus (SLE) are inversely related to disease activity: is it time to routinely supplement patients with SLE with vitamin D? Annals of the rheumatic diseases. 2010; 69(6):1155-7. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4053. doi:10. 1136/ard.2009.120329 PMID: 20439290
14. Cooper JD, Smyth DJ, Walker NM, Stevens H, Burren OS, Wallace C, et al. Inherited variation in vitamin D genes is associated with predisposition to autoimmune disease type 1 diabetes. Diabetes. 2011; 60(5):1624-31. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4054. doi: 10.2337/db10-1656 PMID: 21441443
15. Svoren BM, Volkening LK, Wood JR, Laffel LM. Significant vitamin D deficiency in youth with type 1 diabetes mellitus. The Journal of pediatrics. 2009; 154(1):132-4. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4055. doi: 10.1016/j.jpeds.2008.07.015 PMID: 19187735
16. Yin K, Agrawal DK. Vitamin D and inflammatory diseases. Journal of inflammation research. 2014; 7:69-87. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4050. doi: 10.2147/JIR. S63898 PMID: 24971027
17. Mehta D, Malik AB. Signaling mechanisms regulating endothelial permeability. Physiological reviews. 2006; 86(1):279. 11742629540179944321related:gSNvB1oz9qIJ. PMID: 16371600
18. Cines DB, Pollak ES, Buck CA, Loscalzo J, Zimmerman GA, McEver RP, et al. Endothelial cells in physiology and in the pathophysiology of vascular disorders. Blood. 1998; 91(10):3527-61. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4056. PMID: 9572988
19. Pober JS, Sessa WC. Evolving functions of endothelial cells in inflammation. Nature Reviews Immunology. 2007; 7(10):803. doi: 10.1038/nri2171 PMID: 17893694
20. Dejana E, Tournier-Lasserve E, Weinstein BM. The control of vascular integrity by endothelial cell junctions: molecular basis and pathological implications. Developmental cell. 2009; 16(2):209-21. 8258798865305868001related:4Zb0nc8lnXIJ. doi: 10.1016/j.devcel.2009.01.004 PMID: 19217423
21. Davis CT, Zhu W, Gibson CC, Bowman-Kirigin J, Sorensen L, Ling J, et al. ARF6 Inhibition Stabilizes the Vasculature and Enhances Survival during Endotoxic Shock. Journal of immunology (Baltimore, Md: 1950). 2014. doi: 10.4049/jimmunol.1400309 PMID: 24835390.
22. Zhu W, London NR, Gibson CC, Davis CT, Tong Z, Sorensen LK, et al. Interleukin receptor activates a MYD88-ARNO-ARF6 cascade to disrupt vascular stability. Nature. 2012; 492(7428):252-5. doi:10. 1038/nature11603 PMID: 23143332; PubMed Central PMCID: PMC3521847.
23. London NR, Zhu W, Bozza FA, Smith MCP, Greif DM, Sorensen LK, et al. Targeting Robo4-Dependent Slit Signaling to Survive the Cytokine Storm in Sepsis and Influenza. Science Translational Medicine. 2010; 2(23):23ra19-23ra19. doi: 10.1126/scitranslmed.3000678 PMID: 20375003
24. Goel S, Duda DG, Xu L, Munn LL, Boucher Y, Fukumura D, et al. Normalization of the vasculature for treatment of cancer and other diseases. Physiological reviews. 2011; 91(3):1071-121. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4057. doi: 10.1152/physrev.00038.2010 PMID: 21742796
25. Jones C, Nishiya N, London N, Zhu W, Sorensen L, Chan A, et al. Slit2-Robo4 signalling promotes vascular stability by blocking Arf6 activity. Nature cell biology. 2009. 355377878020714866related: cvF0FEyO7gQJ.
26. Gibson CC, Zhu W, Davis CT, Bowman-Kirigin JA, Chan AC, Ling J, et al. Strategy for Identifying Repurposed Drugs for the Treatment of Cerebral Cavernous Malformation. Circulation. 2014; 131 (3):289-99. doi: 10.1161/CIRCULATIONAHA.114.010403 PMID: 25486933
27. Cheng JB, Levine MA, Bell NH, Mangelsdorf DJ, Russell DW. Genetic evidence that the human CYP2R1 enzyme is a key vitamin D 25-hydroxylase. Proceedings of the National Academy of Sciences of the United States of America. 2004; 101(20):7711-5. doi: 10.1073/pnas.0402490101 PMID: 15128933
28. Horst RL, Reinhardt TA, Reddy GS. Vitamin D metabolism. Vitamin D. 2005; 1:15-36.
29. Holick MF. Vitamin D deficiency. The New England journal of medicine. 2007; 357(3):266-81. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4059. PMID: 17634462
30. Mora JR, Iwata M, von Andrian UH. Vitamin effects on the immune system: vitamins A and D take centre stage. Nature reviews Immunology. 2008; 8(9):685-98. doi: 10.1038/nri2378 PMID: 19172691; PubMed Central PMCID: PMC2906676.
31. Heaney RP, Armas LAG, Shary JR, Bell NH, Binkley N, Hollis BW. 25-Hydroxylation of vitamin D3: relation to circulating vitamin D3 under various input conditions. The American journal of clinical nutrition. 2008; 87(6):1738-42. PMID: 18541563.
32. Broman MT, Kouklis P, Gao X, Ramchandran R, Neamu RF, Minshall RD, et al. Cdc42 regulates adherens junction stability and endothelial permeability by inducing alpha-catenin interaction with the vascular endothelial cadherin complex. Circulation research. 2006; 98(1):73-80. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4063. PMID: 16322481
33. Eliceiri BP, Paul R, Schwartzberg PL, Hood JD, Leng J, Cheresh DA, Selective requirement for Src kinases during VEGF-induced angiogenesis and vascular permeability. Molecular cell. 1999; 4(6):915-24. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4061. PMID: 10635317
34. Sawada J, Urakami T, Li F, Urakami A, Zhu W, Fukuda M, et al. Small GTPase R-Ras regulates integrity and functionality of tumor blood vessels. Cancer cell. 2012; 22(2):235-49. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4062. doi: 10.1016/j.ccr.2012.06.013 PMID: 22897853
35. Wojciak-Stothard B, Ridley AJ. Rho GTPases and the regulation of endothelial permeability. Vascular pharmacology. 2002; 39(4-5):187-99. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4060. PMID: 12747959
36. Allingham MJ, van Buul JD, Burridge K. ICAM-1-mediated, Src-and Pyk2-dependent vascular endothelial cadherin tyrosine phosphorylation is required for leukocyte transendothelial migration. Journal of immunology (Baltimore, Md: 1950). 2007; 179(6):4053-64. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4066.
37. Potter MD, Barbero S, Cheresh DA. Tyrosine phosphorylation of VE-cadherin prevents binding of p120-and beta-catenin and maintains the cellular mesenchymal state. The Journal of biological chemistry. 2005; 280(36):31906-12. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4064. PMID: 16027153
38. Haussler MR, Jurutka PW, Mizwicki M, Norman AW. Vitamin D receptor (VDR)-mediated actions of 1,25(OH)2vitamin D3: genomic and non-genomic mechanisms. Best practice & research Clinical endocrinology & metabolism. 2011; 25(4):543-59. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4067.
39. Norman AW. Minireview: vitamin D receptor: new assignments for an already busy receptor. Endocrinology. 2006; 147(12):5542-8. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4069. PMID: 16946007
40. Norman AW, Myrtle JF, Miogett RJ, Nowicki HG, Williams V, Popjaák G. 1,25-Dihydroxycholecalciferol: Identification of the Proposed Active Form of Vitamin D3 in the Intestine. Science. 1971; 173(3991):51-4. doi: 10.1126/science.173.3991.51 PMID: 4325863
41. Norman AW, Nemere I, Zhou LX, Bishop JE, Lowe KE, Maiyar AC, et al. 1,25(OH)2-vitamin D3, a steroid hormone that produces biologic effects via both genomic and nongenomic pathways. The Journal of steroid biochemistry and molecular biology. 1992; 41(3-8):231-40. Epub 1992/03/01. PMID: 1314073.
42. Boyan BD, Sylvia VL, McKinney N, Schwartz Z. Membrane actions of vitamin D metabolites 1alpha,25 (OH)2D3 and 24R,25(OH)2D3 are retained in growth plate cartilage cells from vitamin D receptor knockout mice. Journal of cellular biochemistry. 2003; 90(6):1207-23. papers://901912B7-6BAE-492FAD36-9E54F72790B3/Paper/p4070. PMID: 14635194
43. Lou Y, Molnár F, Peräkylä M, Qiao S, Kalueff A, St-Arnaud R, et al. 25-Hydroxyvitamin D3 is an agonistic vitamin D receptor ligand. The Journal of steroid biochemistry and molecular biology. 2010; 118 (3):162-70. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4071. doi: 10.1016/j. jsbmb.2009.11.011 PMID: 19944755
44. Meyer MB, Goetsch PD, Pike JW. A downstream intergenic cluster of regulatory enhancers contributes to the induction of CYP24A1 expression by 1alpha,25-dihydroxyvitamin D3. The Journal of biological chemistry. 2010; 285(20):15599-610. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4074. doi: 10.1074/jbc.M110.119958 PMID: 20236932
45. Wang TT, Tavera-Mendoza LE, Laperriere D, Libby E, MacLeod NB, Nagai Y, et al. Large-scale in silico and microarray-based identification of direct 1,25-dihydroxyvitamin D3 target genes. Molecular endocrinology (Baltimore, Md). 2005; 19(11):2685-95. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4073.
46. Zehnder D, Bland R, Chana RS, Wheeler DC, Howie AJ, Williams MC, et al. Synthesis of 1,25-dihydroxyvitamin D(3) by human endothelial cells is regulated by inflammatory cytokines: a novel autocrine determinant of vascular cell adhesion. Journal of the American Society of Nephrology: JASN. 2002; 13 (3):621-9. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4075. PMID: 11856765
47. Thacher TD, Clarke BL. Vitamin D insufficiency. Mayo Clinic proceedings Mayo Clinic. 2011; 86(1):50-60. papers://901912B7-6BAE-492F-AD36-9E54F72790B3/Paper/p4076.
48. Kim DH, Jung YJ, Lee AS, Lee S, Kang KP, Lee TH, et al. COMP-Angiopoietin-1 decreases lipopolysaccharide-induced acute kidney injury. Kidney International. 2009; 76(11):1180-91. doi: 10.1038/ki. 2009.387 PMID: 19812542
49. Nambu H, Nambu R, Oshima Y, Hackett SF, Okoye G, Wiegand S, et al. Angiopoietin 1 inhibits ocular neovascularization and breakdown of the blood - retinal barrier. Gene Ther. 2004; 11(10):865-73. doi: 10.1038/sj.gt.3302230 PMID: 15042118
50. Walsh KB, Teijaro JR, Wilker PR, Jatzek A, Fremgen DM, Das SC, et al. Suppression of cytokine storm with a sphingosine analog provides protection against pathogenic influenza virus. Proceedings of the National Academy of Sciences of the United States of America. 2011; 108(29):12018-23. doi: 10.1073/pnas.1107024108 PMID: 21715659.
51. Chen TC, Persons KS, Lu Z, Mathieu JS, Holick MF. An evaluation of the biologic activity and vitamin D receptor binding affinity of the photoisomers of vitamin D3 and previtamin D3. The Journal of Nutritional Biochemistry. 2000; 11(5):267-72. doi: 10.1016/S0955-2863(00)00077-2 PMID: 10876100
52. Heaney RP, Davies KM, Chen TC, Holick MF, Barger-Lux MJ. Human serum 25-hydroxycholecalciferol response to extended oral dosing with cholecalciferol. The American journal of clinical nutrition. 2003; 77(1):204-10. PMID: 12499343.